Trial Profile
A Prospective Randomized Controlled Multicenter Phase-III Clinical Study to Evaluate the Safety and Effectiveness of NOVOCART 3D Plus Compared to the Standard Procedure Microfracture in the Treatment of Articular Cartilage Defects of the Knee
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Nov 2023
Price :
$35
*
At a glance
- Drugs Autologous chondrocyte implant TETEC (Primary)
- Indications Cartilage disorders; Meniscus disorders
- Focus Registrational; Therapeutic Use
- Sponsors TETEC
- 22 Nov 2023 Status changed from active, no longer recruiting to completed.
- 15 Apr 2023 This trial has been completed in France and Hungary (End Date: 28 Feb 2023).
- 30 Mar 2023 This trial has been completed in Latvia (End Date: 28 Feb 2023), according to European Clinical Trials Database record.